About this trial
Pharmaceutical and neurosurgical treatments reliably ameliorate the cardinal motor symptoms in PD but, they often yield inconsistent outcomes for speech and voice disorders, with some studies showing exacerbation of pre-treatment deficits. Therefore, it is crucial to develop and optimize novel approaches that could simultaneously improve speech and voice deficits in PD and facilitate existing behavioral interventions. This project will investigate the immediate and short-term effects of multiple sessions of HD-tDCS over the left SMA on speech and voice deficits in PD.
Eligibility criteria
Qualifiers
Clinical diagnosis of Parkinson's disease
Native English speakers
Adequate age-relative hearing and vision to perform the outlined tasks
Able to provide their own written consent
Disqualifiers
Neurological disorders besides Parkinson's disease
Previous brain surgery including deep brain stimulation
Clinical diagnosis of dementia
Trial design
Treatments tested in this trial
- Active transcranial direct current stimulation
- Sham transcranial direct current stimulation